SYSTEMIC INTERLEUKIN 1β INHIBITION IN PROLIFERATIVE DIABETIC RETINOPATHY: A Prospective Open-Label Study Using Canakinumab

PURPOSE: To evaluate the effect of systemic interleukin 1β inhibition using canakinumab (Ilaris) on retinal neovascularizations in proliferative diabetic retinopathy. METHODS: Patients with proliferative diabetic retinopathy were enrolled in a prospective uncontrolled pilot study. Canakinumab (150 m...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Retina
Main Authors: Stahel, Marc, Becker, Matthias, Graf, Nicole, Michels, Stephan
Formato: Artigo
Idioma:Inglês
Publicado em: Retina 2016
Assuntos:
Original Study
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4747976/
https://ncbi.nlm.nih.gov/pubmed/26218500
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/IAE.0000000000000701
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados